Asher Bio Secures $55M in Series C Funding for Cancer Therapy
Key Highlights $55 million raised in Series C financing to advance AB248, a novel cancer immunotherapy. New investors include AstraZeneca…
Browsing Tag
Janus Henderson Investors
2 posts
Parse Biosciences Secures $50 Million in Series C Financing and Debt Facility to Propel Single Cell Sequencing Innovations
Key Highlights $50 million raised in Series C equity round and debt facility, led by Soleus Capital, with notable…